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Background
The host restriction factor Apobec3G is a cytidine dea-
minase that incorporates into HIV-1 virions and inter-
feres with viral replication. The HIV-1 accessory protein
Vif subverts Apobec3G by targeting it for proteasomal
degradation. We studied the Apobec3G homomerisation
and the interaction of Apobec3G with Vif in detail.
Methods
We used the MAPPIT two-hybrid technique to analyse
the Apobec3G-Apobec3G and the Apobec3G-Vif inter-
actions in intact human cells. MAPPIT is based on the
functional complementation of a cytokine receptor sig-
nalling pathway.
Results
We propose a model in which Apobec3G N-terminal
domains symmetrically interact via a head-to-head
interface containing residues 122 RLYYFW 127. Muta-
tions in the head-to-head interface abrogate the Apo-
bec3G-Apobec3G interaction. All mutations that inhibit
Apobec3G-Apobec3G binding also inhibit the Apo-
bec3G-Vif interaction, indicating that the head-to head
interface plays an important role in the interaction with
Vif. Only the D128K, P129A and T32Q mutations spe-
cifically affect the Apobec3G-Vif association. In our
model, D128, P129 and T32 cluster at the edge of the
head-to-head interface, possibly forming a Vif binding
site composed of two Apobec3G molecules.
Discussion
We propose that Vif either binds directly at the Apo-
bec3G head-to-head interface or associates with an
RNA-stabilized Apobec3G oligomer.
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